Earth Science Tech (OTCQB: ETST) is leveraging artificial intelligence, proprietary software, and its in-house IT expertise to improve operational efficiency, reduce costs, and support sustainable growth across its pharmacy and telemedicine businesses. The initiative, led by Chief Technology Officer Chris Rose, underscores the company’s focus on technology as a differentiator in the competitive healthcare sector. By developing an integrated software and data platform that connects its pharmacies, curative telehealth business, and My Online Consultation physician network, ETST aims to automate administrative workflows and streamline functions such as inventory, invoicing, shipping, and purchasing.
The platform’s ability to automate routine tasks could significantly reduce operational overhead while allowing staff to focus on higher-value activities. Moreover, ETST sees an opportunity to offer its technology to other clinics as a white-label service, potentially creating a new revenue stream and extending the company’s reach beyond its own operations. This strategic move aligns with the broader trend of healthcare organizations adopting digital tools to enhance efficiency and patient care.
Beyond operational improvements, ETST is also using customer relationship management systems and proprietary marketing tools to personalize patient communications, encourage retention, and strengthen brand loyalty. By combining AI-assisted development with human oversight, the company aims to expand its technology capabilities, introduce new services, and build long-term shareholder value. The human oversight component is particularly important in healthcare, where accuracy and compliance are critical, and it may help the company mitigate risks associated with automation.
The announcement comes as healthcare providers increasingly turn to AI and data integration to manage costs and improve outcomes. For ETST, which operates a vertically integrated healthcare platform combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment, the technology initiative could enhance the seamless integration of patient care from consultation to fulfillment. The company’s core value proposition rests on this integration, and the new platform is designed to reinforce it.
Investors and industry observers may view the move as a sign of ETST’s commitment to innovation and operational discipline. By investing in proprietary technology and in-house expertise, the company is positioning itself to scale efficiently and adapt to evolving market demands. The potential to license its platform to other clinics could also open up new growth avenues, although the company has not disclosed specific financial targets or timelines for that initiative.
The full article on ETST’s technology strategy can be accessed through this link, and additional information about the company is available at www.EarthScienceTech.com. For ongoing updates, ETST maintains a newsroom at https://nnw.fm/ETST. The announcement was distributed via NetworkNewsWire, a communications platform focused on financial news and content distribution. NetworkNewsWire is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions through InvestorWire and offers services such as editorial syndication to 5,000+ outlets and social media distribution.
